Track topics on Twitter Track topics that are important to you
Variants of the ARMS2 gene may be associated with the results of photodynamic therapy in wet age-related macular degeneration, according to a study.The 65 patients included in the study were recruited from the ophthalmology department at Kobe University Hospital in Japan. All patients had previously taken part in a study evaluating the 12-month outcomes of PDT in wet AMD between 2005 and 2008. As the authors noted, anti-VEGF agents were not available in Japan at the time and PDT was commonly used to treat AMD. In addition, PDT is still considered a beneficial therapy in patients with polypoidal choroidal vasculopathy, which is frequently diagnosed in Japan.
Original Article: Gene variants in AMD may predict 3-year outcomes with PDTNEXT ARTICLE
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...